Anti-inflammatory properties of N-phenylanthranilic acid derivatives in relation to uncoupling of oxidative phosphorylation.
D000251:Adenosine Triphosphatases / Q000378:metabolism; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology*; D003864:Depression, Chemical; D004140:Dinitrophenols / Q000494:pharmacology; D005260:Female; D005439:Flufenamic Acid / Q000494:pharmacology; D007213:Indomethacin / Q000494:pharmacology; D008297:Male; D008528:Mefenamic Acid / Q000494:pharmacology; D008930:Mitochondria, Liver / Q000201:enzymology / Q000378:metabolism; D009840:Oligomycins / Q000494:pharmacology; D010085:Oxidative Phosphorylation / Q000187:drug effects*; D010101:Oxygen Consumption / Q000187:drug effects; D010113:Oxyphenbutazone / Q000494:pharmacology; D010653:Phenylbutazone / Q000494:pharmacology; D051381:Rats; D012459:Salicylates / Q000494:pharmacology; D062367:ortho-Aminobenzoates / Q000494:pharmacology*
D000893:Anti-Inflammatory Agents; D004140:Dinitrophenols; D009840:Oligomycins; D012459:Salicylates; D062367:ortho-Aminobenzoates; D008528:Mefenamic Acid; D005439:Flufenamic Acid; D000251:Adenosine Triphosphatases; D010653:Phenylbutazone; D010113:Oxyphenbutazone; D007213:Indomethacin